| Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia D Singh, S Narayanan, CP Müller, MT Swogger, NJY Chear, EB Dzulkapli, ... Journal of ethnopharmacology 233, 34-40, 2019 | 53 | 2019 |
| Focus: Plant-based Medicine and Pharmacology: Kratom and Pain Tolerance: A Randomized, Placebo-Controlled, Double-Blind Study B Vicknasingam, WT Chooi, AA Rahim, D Ramachandram, D Singh, ... The Yale Journal of Biology and Medicine 93 (2), 229, 2020 | 50 | 2020 |
| LCMS—a review and a recent update PR Kumar, SR Dinesh, R Rini J Pharm Pharm Sci 5, 377-391, 2016 | 26 | 2016 |
| Chewable lozenge formulation-A review MS Umashankar, SR Dinesh, R Rini, KS Lakshmi, N Damodharan Int Res J Pharm 7 (4), 9-16, 2016 | 22 | 2016 |
| The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials CS Kow, DS Ramachandram, SS Hasan Journal of Infection and Chemotherapy 28 (2), 257-265, 2022 | 19 | 2022 |
| The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of randomized trials CS Kow, DS Ramachandram, SS Hasan Immunopharmacology and Immunotoxicology 44 (1), 28-34, 2022 | 16 | 2022 |
| The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID‐19: A meta‐analysis of randomized trials CS Kow, LH Lee, DS Ramachandram, SS Hasan, LC Ming, HP Goh Immunity, inflammation and disease 10 (2), 255-264, 2022 | 14 | 2022 |
| The effectiveness of mRNA‐1273 vaccine against COVID‐19 caused by Delta variant: A systematic review and meta‐analysis CS Kow, DS Ramachandram, SS Hasan Journal of Medical Virology 94 (5), 2269-2274, 2022 | 12 | 2022 |
| Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis CS Kow, DS Ramachandram, SS Hasan Hypertension Research 45 (2), 360-363, 2022 | 12 | 2022 |
| Pharmacokinetics and pharmacodynamics of mitragynine, the principle alkaloid of Mitragyna speciosa: Present knowledge and future directions in perspective of pain DS Ramachandram, T Damodaran, H Zainal, V Murugaiyah, ... Journal of basic and clinical physiology and pharmacology 31 (1), 2020 | 9 | 2020 |
| Risk of severe illness in patients infected with SARS-CoV-2 of Delta variant: a systematic review and meta-analysis CS Kow, DS Ramachandram, SS Hasan Infectious Diseases 54 (8), 614-617, 2022 | 7 | 2022 |
| Use of sulforaphane in COVID-19: Clinical trials are needed CS Kow, DS Ramachandram, SS Hasan Molecular immunology 145, 78-79, 2022 | 6 | 2022 |
| The effect of curcumin on the risk of mortality in patients with COVID‐19: A systematic review and meta‐analysis of randomized trials CS Kow, DS Ramachandram, SS Hasan Phytotherapy Research, 2022 | 6 | 2022 |
| Effects of angiotensin II receptor blockers on the risk of mortality in patients with COVID-19: an updated systematic review and meta-analysis of randomized trials CS Kow, DS Ramachandram, SS Hasan American Journal of Hypertension 35 (8), 763-764, 2022 | 5 | 2022 |
| Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials CS Kow, A Javed, D Ramachandram, SS Hasan Expert Review of Anti-infective Therapy 20 (4), 567-575, 2022 | 5 | 2022 |
| Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far? A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui, F Philippart Drugs 83 (1), 1-36, 2023 | 4 | 2023 |
| The use of tenofovir in patients with COVID‐19 CS Kow, DS Ramachandram, SS Hasan HIV medicine 23 (7), 807-808, 2022 | 4* | 2022 |
| Coenzyme Q10 therapy in patients with post COVID-19 condition CS Kow, DS Ramachandram, SS Hasan The Lancet Regional Health–Europe 25, 2023 | 3 | 2023 |
| The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis CSC Kow, DS Ramachandram, SS Hasan Inflammopharmacology 30 (1), 149-157, 2022 | 3 | 2022 |
| Future of antivirals in COVID-19: The case of favipiravir CS Kow, DS Ramachandram, SS Hasan International Immunopharmacology 103, 108455, 2022 | 3 | 2022 |
Francisco LeónAsistant Professor在 mailbox.sc.edu 的电子邮件经过验证
